Allez plus loin

In this section, you will learn more about Gattefossé Pharmaceuticals expertise, through news, hot topics and publications at the cutting edge of science, you can browse through a library of on-demands webinars, and download our latest brochures.

Nouveautés et sujets d'actualité

Meet us at CPHI Frankfurt 2025!

  • News

You can schedule a meeting with our team or come to our booth 8.0S8

In the spotlight: spot-on solutions!

  • Animal Health

Discover how Gattefossé excipients enhance the formulation of spot-on veterinary treatments!

Soft chews, the pet-fect dosage form!

  • Animal Health

Learn how Gattefossé excipients can be used for this convenient veterinary dosage form!

Voir Tous

Nos webinaires

Beyond the Capsule: Unlocking the Full Potential of Lipid Excipients in Oral Solid Dosage Forms

  • Lipids and polymers
  • Bioavailability enhancement
  • Hot melt extrusion
  • Modified-release

This presentation from November 4th, 2025 highlights emerging research and practical formulation strategies that expand the use of lipid excipients in oral tablet development, including ternary ASDs, sustained release products, and solid SEDDS formulations.

A capsule transforming into a tablet

A toolbox for oral peptide delivery

  • Bioavailability enhancement
  • Oral peptides delivery

Oral delivery of peptides encounters many hurdles, as they are subject to degradation in the gastro-intestinal tract, leading to poor oral bioavailability. Different strategies have been developed: the objective of this webinar is to give formulators clues on how to use lipid excipients for enhanced oral peptide delivery.

Nos dernières publications

Impact of gastric phase simulation on the in vitro lipolysis of lipid-based formulations containing ticagrelor and fenofibrate

  • Poster

nov 2025

The study examines how adding a simulated gastric phase before intestinal lipolysis affects the solubilization of two lipophilic drugs, highlighting that gastric digestion improves in vitro prediction of pharmacokinetics and formulation discrimination.

Assessing the performance of lipids as surfactants to enhance the release profile of a model BCS class IV compound from ASD

  • Poster

nov 2025

This study aimed to develop Amorphous Solid Dispersions (ASDs) of anacetrapib, a lipophilic BCS class IV drug, using Hot Melt Extrusion (HME) with lipid-based excipients as surfactants to improve dissolution. A secondary goal was to establish a robust method for incorporating solid or semi-solid excipients into powder blends for HME without requiring specialized feeding ports.

Voir Tous

Nos dernières brochures

Gattefosse Brochure Safe and efficient skin drug delivery

  • Brochure

  • Topical/Transdermal
Gattefosse Brochure Safe and efficient skin drug delivery

Gelucire 44/14

  • Brochure

Learn how to use this self-emulsifying excipient to increase oral drug bioavailability

  • Oral
Télécharger (.pdf - 2.14 Mo)
gelucire-44-14_self-emulsifying-excipient-for-solubility-and-oral-bioavailability-enhancement
Voir Tous